[9] BPC-157 and and the Central Nervous System The potential of BPC-157 has been investigated in a murine model of traumatic brain injury (TBI), suggesting positive outcomes
Patients carrying specific GLP1R rs6923761 genotypes may show enhanced satiety signaling with semaglutide, while those with FTO rs9939609 variants may benefit from earlier dose escalation to achieve target weight loss
These changes have been linked to improvements in insulin sensitivity and metabolic parameters, potentially through modulation of the gutpancreas hormonal axis (139)
DOI: 10.1590/S1676-24442009000100007 36
Chewcharat A, Chewcharat P, Liu W, Cellini J, Phipps EA, Melendez Young JA et al (2022) The effect of levocarnitine supplementation on dialysis-related hypotension: a systematic review, meta-analysis, and trial sequential analysis